Business Quant data puts insider holdings in RNLXY at 32.68Mn shares across insiders' latest Form 4 filings, unchanged from the end of Q2 2026 and Q3 2025.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | School Of Medicine At Mount Sinai Icahn | TenPercentOwner | 32,683,998 | 0 | 32,683,998 | 100.0% | 05 Nov, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 01 Nov, 2024 | School Of Medicine At Mount Sinai Icahn | TenPercentOwner | Acquired J | 13,366,750 | $0.12 | $1.55Mn | 32,683,998 | Direct |
| 11 Jun, 2024 | Joel R Jung | Interim Chief Financial Office | Acquired A | 60,000 | $0.00 | $0 | 60,000 | Direct |
| 24 Apr, 2024 | School Of Medicine At Mount Sinai Icahn | TenPercentOwner | Acquired J | 9,360,374 | $0.25 | $2.34Mn | 19,317,248 | Direct |
| 20 Nov, 2023 | Daniel J Levangie | Director | Acquired A | 95,000 | $0.00 | $0 | 95,000 | Direct |
| 20 Nov, 2023 | Christopher Mills | Director, TenPercentOwner | Acquired A | 95,000 | $0.00 | $0 | 95,000 | Direct |
| 20 Nov, 2023 | Howard Jr Doran | Chief Business Officer | Acquired A | 300,000 | $0.00 | $0 | 300,000 | Direct |
| 20 Nov, 2023 | Catherine Coste | Director | Acquired A | 95,000 | $0.00 | $0 | 95,000 | Direct |
| 20 Nov, 2023 | Chirag R. Parikh | Director | Acquired A | 95,000 | $0.00 | $0 | 95,000 | Direct |
| 10 Jul, 2023 | Thomas H Mclain | President | Acquired A | 200,000 | $0.00 | $0 | 200,000 | Direct |
| 06 Jul, 2023 | Thomas H Mclain | President | Acquired A | 394,486 | $0.00 | $0 | 394,486 | Direct |
| 06 Jul, 2023 | O. James Sterling | Chief Financial Officer | Acquired A | 575,160 | $0.00 | $0 | 575,160 | Direct |
| 06 Jul, 2023 | Catherine Coste | Director | Acquired A | 190,000 | $0.00 | $0 | 190,000 | Direct |
| 06 Jul, 2023 | Fergus Fleming | Chief Technical Officer | Acquired A | 352,902 | $0.00 | $0 | 352,902 | Direct |
| 06 Jul, 2023 | James Renwick Mccullough | Chief Executive Officer | Acquired A | 875,017 | $0.00 | $0 | 875,017 | Direct |
| 06 Jul, 2023 | Michael J. Donovan | Chief Medical Officer | Acquired A | 85,731 | $0.00 | $0 | 85,731 | Direct |